Discovery Of Abbv-744, A First-In-Class Highly Bdii-Selective Bet Bromodomain Inhibitor

CANCER RESEARCH(2018)

引用 4|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要